HC Surgical Specialists Limited (SGX:1B1)

HC Surgical Specialists Income Statement

Financials in millions SGD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 30, 2024	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Operating Revenue	19.13	18.81	19.08	19.31	23.36	16.72
Other Revenue	0.24	0.24	0.17	0.11	0.11	0.17
Revenue	19.38	19.05	19.25	19.42	23.47	16.89
Revenue Growth (YoY)	3.33%	-1.03%	-0.87%	-17.25%	38.95%	-7.80%
Cost of Revenue	9.92	9.8	9.28	9.48	10.61	7.91
Gross Profit	9.46	9.25	9.98	9.94	12.86	8.98
Selling, General & Admin	0.02	0.02	0.02	0.06	-0.16	0.17
Other Operating Expenses	1.66	1.67	2.26	1.49	2.11	1.66
Operating Expenses	3.5	3.49	4.03	3.22	3.66	3.16
Operating Income	5.97	5.76	5.95	6.72	9.2	5.82
Interest Expense	-0.41	-0.5	-0.64	-0.47	-0.21	-0.41
Interest & Investment Income	0.66	0.77	0.82	0.82	0.48	0.69
Earnings From Equity Investments	0.49	-0.09	-	-	-	-
Other Non Operating Income (Expenses)	-0.93	-0.78	0.29	0.53	-0.09	1.93
EBT Excluding Unusual Items	5.78	5.16	6.42	7.59	9.39	8.03
Impairment of Goodwill	-	-	-0.68	-0.75	-	-0.72
Gain (Loss) on Sale of Investments	-0.85	0.05	-1.62	0.99	0.31	-1.98
Gain (Loss) on Sale of Assets	0.01	0.01	0	-0.02	0	0.2
Asset Writedown	-0.18	-0.16	-0.13	-0.07	-0	-0.14
Other Unusual Items	0.03	-	0.06	-0.01	0.57	-0.08
Pretax Income	4.79	5.06	4.05	7.75	10.27	5.31
Income Tax Expense	0.8	1.12	1.07	0.94	1.41	0.78
Earnings From Continuing Operations	3.99	3.94	2.99	6.8	8.85	4.53
Minority Interest in Earnings	-0.22	-0.09	-0.07	-0.42	-0.85	-0.54
Net Income	3.78	3.85	2.92	6.38	8	3.99
Net Income to Common	3.78	3.85	2.92	6.38	8	3.99
Net Income Growth	-12.62%	31.76%	-54.25%	-20.25%	100.65%	-44.67%
Shares Outstanding (Basic)	154	152	149	149	150	150
Shares Outstanding (Diluted)	154	152	149	149	150	150
Shares Change (YoY)	2.65%	2.28%	-	-0.72%	0.02%	0.60%
EPS (Basic)	0.02	0.03	0.02	0.04	0.05	0.03
EPS (Diluted)	0.02	0.03	0.02	0.04	0.05	0.03
EPS Growth	-14.81%	28.82%	-54.25%	-19.68%	100.61%	-45.00%
Free Cash Flow	7.16	6.23	6.51	6.84	10.24	5.21
Free Cash Flow Per Share	0.05	0.04	0.04	0.05	0.07	0.03
Dividend Per Share	0.015	0.014	0.020	0.026	0.040	0.020
Dividend Growth	-11.76%	-30.00%	-23.08%	-35.00%	100.00%	-9.09%
Gross Margin	48.83%	48.55%	51.82%	51.18%	54.80%	53.16%
Operating Margin	30.79%	30.23%	30.88%	34.59%	39.20%	34.45%
Profit Margin	19.48%	20.19%	15.16%	32.85%	34.09%	23.61%
Free Cash Flow Margin	36.93%	32.70%	33.82%	35.20%	43.63%	30.82%
EBITDA	6.41	6.26	6.39	7.22	9.69	6.24
EBITDA Margin	33.09%	32.83%	33.17%	37.20%	41.30%	36.97%
D&A For EBITDA	0.45	0.5	0.44	0.51	0.49	0.43
EBIT	5.97	5.76	5.95	6.72	9.2	5.82
EBIT Margin	30.79%	30.23%	30.88%	34.59%	39.20%	34.45%
Effective Tax Rate	16.67%	22.17%	26.35%	12.19%	13.77%	14.74%

Source: S&P Capital IQ. Standard template. Financial Sources.